Skip to Main Content

Paper Details

Risk of Hospitalization and Death Associated With Pimavanserin Use in Older Adults With Parkinson Disease.
Neurology
25
2021
Author NameAffiliation
George Caleb AlexanderJohns Hopkins University School of Medicine Center for Drug Safety and Effectiveness (Y.J.H., Johns Hopkins University Department of Epidemiology (G.C.A., Johns Hopkins Bloomberg School of Public Health, MD Institute for Safe Medication Practices (T.J.M.), Milken Institute School of Public Health, George Washington University
Hemalkumar B MehtaJohns Hopkins University School of Medicine Center for Drug Safety and Effectiveness (Y.J.H., Johns Hopkins University Department of Epidemiology (G.C.A., Johns Hopkins Bloomberg School of Public Health, MD Institute for Safe Medication Practices (T.J.M.), Milken Institute School of Public Health, George Washington University
  • 1 - 2

Datasets

Release 1.2